Michael DiVecchia

Direttore operativo presso Elicio Therapeutics, Inc. (Old)

Health Technology

Consumer Services

Posizioni attive di Michael DiVecchia

Società	Posizione	Inizio	Fine
Elicio Therapeutics, Inc. (Old) Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.	Direttore operativo	-	-

Società	Posizione	Inizio	Fine
ELICIO THERAPEUTICS, INC.	Direttore operativo	01/02/2022	01/01/2024
ELICIO THERAPEUTICS, INC.	Ufficiale delle Risorse Umane	01/02/2022	01/01/2024

Syracuse University

Undergraduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Settori

Health Technology	3
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
ELICIO THERAPEUTICS, INC.	Health Technology

Aziende private	1
Elicio Therapeutics, Inc. (Old) Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.	Health Technology

Aziende private

Health Technology